Hovnanian Enterprises, Inc. PFD DEP1/1000A (HOVNP)

Total Non-Current Liabilities

$1.16B

Quarterly · Period ending: · USD

HOVNP logo

HOVNP Total Non-Current Liabilities

Latest reported$1.16B
HOVNP Quarterly Total Non-Current Liabilities ($196.70M → $1.16B)
High-resolution chart · PNG

HOVNP total non-current liabilities history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Hovnanian Enterprises, Inc. PFD DEP1/1000A Total Non-Current Liabilities — Quarterly (USD)
Period endingTotal Non-Current Liabilities (USD)
1,163,525,000
1,325,067,000
1,268,427,000
1,305,808,000
1,175,463,000
1,133,672,000
1,279,955,000
1,310,326,000
1,174,079,000
1,126,451,999
1,264,061,000
1,415,465,000
1,414,387,000
1,569,812,000
1,579,804,000
1,629,425,000
1,834,695,000
1,782,000,000
1,820,672,000
1,618,443,000
1,881,725,000
1,992,590,000
1,997,023,000
2,016,534,000
2,050,329,000
2,189,000,000
2,067,582,000
2,012,834,000
2,074,439,000
2,055,496,000
1,793,287,000
1,777,227,000
1,984,868,000
1,980,895,000
1,759,452,000
1,938,213,000
1,870,784,000
1,863,220,000
2,031,384,000
1,871,280,000
2,109,569,000
2,063,776,000
2,260,102,000
2,141,385,000
2,389,391,000
2,360,875,000
2,337,380,000
1,892,743,000
1,897,227,000
1,888,720,000
1,874,773,000
1,730,821,000
1,887,790,000
1,696,671,000
1,690,713,000
1,569,277,000
503,708,000
1,517,405,000
1,619,213,000
1,665,930,000
1,699,038,000
1,691,249,000
1,689,798,000
1,658,225,000
91,733,000
1,841,003,000
1,859,568,000
1,839,313,000
1,796,962,000
2,052,449,000
2,603,680,000
2,713,359,000
2,730,752,000
2,281,106,000
2,258,024,000
2,351,229,000
2,761,963,000
2,773,886,000
2,291,981,000
2,305,950,000
2,637,402,000
254,691,000
1,738,700,000
1,519,547,000
1,259,098,000
1,387,331,000
1,207,071,000
1,132,896,000
1,155,201,000
1,108,780,000
1,263,216,000
817,841,000
819,767,000
701,574,000
661,514,000
662,167,000
673,519,000
672,767,000
607,881,000
410,034,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.